175 related articles for article (PubMed ID: 12186929)
1. Interaction with decay-accelerating factor facilitates coxsackievirus B infection of polarized epithelial cells.
Shieh JT; Bergelson JM
J Virol; 2002 Sep; 76(18):9474-80. PubMed ID: 12186929
[TBL] [Abstract][Full Text] [Related]
2. Decay-accelerating factor binding determines the entry route of echovirus 11 in polarized epithelial cells.
Sobo K; Rubbia-Brandt L; Brown TD; Stuart AD; McKee TA
J Virol; 2011 Dec; 85(23):12376-86. PubMed ID: 21917947
[TBL] [Abstract][Full Text] [Related]
3. Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell line.
Riabi S; Harrath R; Gaaloul I; Bouslama L; Nasri D; Aouni M; Pillet S; Pozzetto B
J Biomed Sci; 2014 May; 21(1):50. PubMed ID: 24885774
[TBL] [Abstract][Full Text] [Related]
4. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
Milstone AM; Petrella J; Sanchez MD; Mahmud M; Whitbeck JC; Bergelson JM
J Virol; 2005 Jan; 79(1):655-60. PubMed ID: 15596863
[TBL] [Abstract][Full Text] [Related]
5. Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF.
Spiller OB; Goodfellow IG; Evans DJ; Hinchliffe SJ; Morgan BP
J Gen Virol; 2002 Jan; 83(Pt 1):45-52. PubMed ID: 11752699
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3.
Pasch A; Küpper JH; Wolde A; Kandolf R; Selinka HC
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3153-3158. PubMed ID: 10567646
[TBL] [Abstract][Full Text] [Related]
7. More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55).
Jimenez-Clavero MA; Escribano-Romero E; Ley V; Spiller OB
J Gen Virol; 2005 May; 86(Pt 5):1369-1377. PubMed ID: 15831949
[TBL] [Abstract][Full Text] [Related]
8. Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.
Newcombe NG; Johansson ES; Au G; Lindberg AM; Barry RD; Shafren DR
J Virol; 2004 Feb; 78(3):1431-9. PubMed ID: 14722298
[TBL] [Abstract][Full Text] [Related]
9. Echovirus 7 entry into polarized intestinal epithelial cells requires clathrin and Rab7.
Kim C; Bergelson JM
mBio; 2012; 3(2):. PubMed ID: 22496312
[TBL] [Abstract][Full Text] [Related]
10. Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells.
Patel KP; Coyne CB; Bergelson JM
J Virol; 2009 Nov; 83(21):11064-77. PubMed ID: 19710132
[TBL] [Abstract][Full Text] [Related]
11. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors.
Bergelson JM; Modlin JF; Wieland-Alter W; Cunningham JA; Crowell RL; Finberg RW
J Infect Dis; 1997 Mar; 175(3):697-700. PubMed ID: 9041347
[TBL] [Abstract][Full Text] [Related]
12. Expression of human decay-accelerating factor on intestinal epithelium of transgenic mice does not facilitate infection by the enteral route.
Pan J; Zhang L; Odenwald MA; Shen L; Turner JR; Bergelson JM
J Virol; 2015 Apr; 89(8):4311-8. PubMed ID: 25653430
[TBL] [Abstract][Full Text] [Related]
13. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.
Coyne CB; Bergelson JM
Cell; 2006 Jan; 124(1):119-31. PubMed ID: 16413486
[TBL] [Abstract][Full Text] [Related]
14. Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70.
Haddad A; Nokhbeh MR; Alexander DA; Dawe SJ; Grisé C; Gulzar N; Dimock K
J Virol; 2004 Mar; 78(6):2674-81. PubMed ID: 14990687
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).
Bergelson JM; Mohanty JG; Crowell RL; St John NF; Lublin DM; Finberg RW
J Virol; 1995 Mar; 69(3):1903-6. PubMed ID: 7531780
[TBL] [Abstract][Full Text] [Related]
16. Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor.
Pan J; Narayanan B; Shah S; Yoder JD; Cifuente JO; Hafenstein S; Bergelson JM
J Virol; 2011 Jul; 85(14):7436-43. PubMed ID: 21561916
[TBL] [Abstract][Full Text] [Related]
17. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry.
Shafren DR; Dorahy DJ; Ingham RA; Burns GF; Barry RD
J Virol; 1997 Jun; 71(6):4736-43. PubMed ID: 9151867
[TBL] [Abstract][Full Text] [Related]
18. Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55).
Krautkrämer E; Zeier M
J Virol; 2008 May; 82(9):4257-64. PubMed ID: 18305044
[TBL] [Abstract][Full Text] [Related]
19. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism.
Selinka HC; Wolde A; Sauter M; Kandolf R; Klingel K
Med Microbiol Immunol; 2004 May; 193(2-3):127-31. PubMed ID: 12920584
[TBL] [Abstract][Full Text] [Related]
20. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.
Shafren DR; Williams DT; Barry RD
J Virol; 1997 Dec; 71(12):9844-8. PubMed ID: 9371658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
